PHARMACOLOGY OF ADRIAMYCIN - THE MESSAGE TO THE CLINICIAN

被引:29
作者
CUMMINGS, J
SMYTH, JF
机构
来源
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 1988年 / 24卷 / 04期
关键词
D O I
10.1016/0277-5379(88)90283-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:579 / 582
页数:4
相关论文
共 16 条
[1]  
BACHUR NR, 1979, CANCER TREAT REP, V63, P817
[3]   STUDIES ON THE INVIVO DISPOSITION OF ADRIAMYCIN IN HUMAN-TUMORS WHICH EXHIBIT DIFFERENT RESPONSES TO THE DRUG [J].
CUMMINGS, J ;
MCARDLE, CS .
BRITISH JOURNAL OF CANCER, 1986, 53 (06) :835-838
[4]   DETERMINATION OF ANTHRACYCLINE PURITY IN PATIENT SAMPLES AND IDENTIFICATION OF INVITRO CHEMICAL-REDUCTION PRODUCTS BY APPLICATION OF A MULTI-DIODE ARRAY HIGH-SPEED SPECTROPHOTOMETRIC DETECTOR [J].
CUMMINGS, J ;
MORRISON, JG ;
WILLMOTT, N .
JOURNAL OF CHROMATOGRAPHY, 1986, 381 (02) :373-384
[5]   MARKED INTER-PATIENT VARIATION IN ADRIAMYCIN BIOTRANSFORMATION TO 7-DEOXYAGLYCONES - EVIDENCE FROM METABOLITES IDENTIFIED IN SERUM [J].
CUMMINGS, J ;
MILSTEAD, R ;
CUNNINGHAM, D ;
KAYE, S .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (08) :991-1001
[6]   DISPOSITION KINETICS OF ADRIAMYCIN, ADRIAMYCINOL AND THEIR 7-DEOXYAGLYCONES IN AKR MICE BEARING A SUB-CUTANEOUSLY GROWING RIDGWAY OSTEOGENIC-SARCOMA (ROS) [J].
CUMMINGS, J ;
MERRY, S ;
WILLMOTT, N .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (04) :451-460
[7]  
CUMMINGS J, 1987, BIOCHEM PHARMACOL, V36, P521
[8]  
DRUCK MN, 1984, CANCER, V53, P1667, DOI 10.1002/1097-0142(19840415)53:8<1667::AID-CNCR2820530808>3.0.CO
[9]  
2-D
[10]   LIQUID-CHROMATOGRAPHIC ANALYSIS OF ADRIAMYCIN AND METABOLITES IN BIOLOGICAL-FLUIDS [J].
ISRAEL, M ;
PEGG, WJ ;
WILKINSON, PM ;
GARNICK, MB .
JOURNAL OF LIQUID CHROMATOGRAPHY, 1978, 1 (06) :795-809